Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra
P Worms, H Depoortere, A Durand, et al.
Annales Francaises D'Anesthesie Et De Reanimation
|
August 6, 2011
[Risk of accumulation of CO₂ in the oxygen chamber in "HOOD" (Experimental study on test bed)]
A Caron Salloum, T Rakza, J-F Diependaele, et al.
Gynecologie, Obstetrique, Fertilite & Senologie
|
February 28, 2017
[Pregnancy and delivery of teenagers: Is the obstetrical prognosis worst between 13-15years old?]
C Wemaux-Denis, C Garabedian, A Huc, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1989
Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat
D Garrigou-Gadenne, J T Burke, A Durand, et al.
Journal of Receptor and Signal Transduction Research
|
January 1, 1997
Development of stable cell lines expressing different subtypes of GABAA receptors
F Besnard, Y Even, V Itier, et al.
European Journal of Pharmacology
|
January 25, 1996
Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes
P Avenet, J Léonardon, F Besnard, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1986
Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects
H Depoortere, B Zivkovic, K G Lloyd, et al.
L'Encephale
|
January 1, 1990
[A specific domain (the omega 1 site) of the GABA(A) receptor may be implicated in the hypnotic effects of zolpidem]
J Benavides, H Depoortere, D Sanger, et al.
Journal of Affective Disorders
|
May 20, 1999
Preclinical profile of befloxatone, a new reversible MAO-A inhibitor
O Curet, G Damoiseau-Ovens, C Sauvage, et al.
Molecular Pharmacology
|
June 1, 1995
Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin
P Granger, B Biton, C Faure, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra
P Worms, H Depoortere, A Durand, et al.
Annales Francaises D'Anesthesie Et De Reanimation
|
August 6, 2011
[Risk of accumulation of CO₂ in the oxygen chamber in "HOOD" (Experimental study on test bed)]
A Caron Salloum, T Rakza, J-F Diependaele, et al.
Gynecologie, Obstetrique, Fertilite & Senologie
|
February 28, 2017
[Pregnancy and delivery of teenagers: Is the obstetrical prognosis worst between 13-15years old?]
C Wemaux-Denis, C Garabedian, A Huc, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1989
Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat
D Garrigou-Gadenne, J T Burke, A Durand, et al.
Journal of Receptor and Signal Transduction Research
|
January 1, 1997
Development of stable cell lines expressing different subtypes of GABAA receptors
F Besnard, Y Even, V Itier, et al.
European Journal of Pharmacology
|
January 25, 1996
Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes
P Avenet, J Léonardon, F Besnard, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1986
Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects
H Depoortere, B Zivkovic, K G Lloyd, et al.
L'Encephale
|
January 1, 1990
[A specific domain (the omega 1 site) of the GABA(A) receptor may be implicated in the hypnotic effects of zolpidem]
J Benavides, H Depoortere, D Sanger, et al.
Journal of Affective Disorders
|
May 20, 1999
Preclinical profile of befloxatone, a new reversible MAO-A inhibitor
O Curet, G Damoiseau-Ovens, C Sauvage, et al.
Molecular Pharmacology
|
June 1, 1995
Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin
P Granger, B Biton, C Faure, et al.
Page
of 5